Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Bruker announces strategic collaboration with Atinary Technologies to advance Self-Driving Laboratories

Bruker Corporation today announced an expanded strategic collaboration with Atinary Technologies Inc., the pioneer of Self-Driving Labs® technologies and AI-driven R&D with applications in pharmaceuticals, chemicals, energy, and materials.

From SciY 12 Aug 2026

Contaminated soil can bring hazardous lead dust into homes

Lead contamination in soil tracked inside homes can cause dangerous indoor lead dust levels even in residences with no interior lead-based paint, according to researchers with the Rutgers Environmental, Occupational and Health Sciences Institute in collaboration with community scientists from the East Trenton Collaborative.

11 Aug 2026

Stretchable catheter could help identify high-risk arterial plaque

We all know about plaque from dreaded trips to the dentist. But plaque can also build up inside the arteries, taking the form of fatty deposits that can potentially restrict blood flow.

11 Aug 2026

Study: Nearly all personal care and cleaning products contain undisclosed chemicals

A new study of sunscreens, baby lotions, shampoos, soaps, and other everyday products found that nearly all contained chemicals not disclosed on their labels.

11 Aug 2026

New review urges proteostatic fitness standards for stem cell therapies

Stem cell therapies have expanded rapidly, with more than 115 clinical trials involving over 1,200 patients approved by late 2024. The U.S. Food and Drug Administration (FDA) recently approved Ryoncil (remestemcel‑L) for children with steroid‑refractory acute graft‑versus‑host disease, signaling a major shift toward routine clinical use.

11 Aug 2026

New research agreement funds xenoliver transplant center at Baylor

Baylor College of Medicine today announced that a new research agreement with United Therapeutics Corporation, a public benefit corporation, will provide up to $5 million a year for five years to establish the Baylor College of Medicine Center for Xenoliver Transplantation and Immunomodulation (XTI), dedicated to advancing scientific understanding of xenoliver transplantation.

10 Aug 2026

Accelerating life science computing with AI-ready infrastructure

Discover how computing is transforming life science research through AI infrastructure, GPU acceleration, and genomics.

From Advantech 10 Aug 2026

Study finds more than half of mapped US parks lie near toxic chemical-reporting facilities

A nationwide geospatial analysis of 151,366 publicly accessible parks found that 52.6% lay within two miles of at least one industrial facility reporting toxic chemical management to the EPA, while 17.7% had parkland within two miles of a current or former Superfund site. The study mapped proximity rather than contamination or exposure, highlighting locations where targeted environmental assessment and healthier urban planning may be warranted.

9 Aug 2026

Integrated nanomaterials offer new strategies for cancer immunotherapy

Immune checkpoint inhibitors, cancer vaccines and cellular therapies have reshaped oncology, yet most patients still do not achieve lasting benefit.

9 Aug 2026

Targeted dendritic cell vaccines emerge as a major step forward in cancer immunotherapy

A major step forward in cancer immunotherapy is emerging through the growing development of dendritic cell vaccines, a highly targeted approach designed to harness the body's own immune system to fight tumors.

5 Aug 2026

Artificial cells offer new insights into living cell behavior

Using simple artificial cells, a research group led by Makito Miyazaki of the RIKEN Center for Integrative Medical Sciences (IMS) in Japan have uncovered fundamental physical principles that govern how living cells change their shape.

5 Aug 2026

New 3D brain tissue model accelerates Alzheimer's drug development

How can Alzheimer's research be made faster, better, and more effective? After decades of intensive research worldwide and despite recent therapeutic advances, scientists have not managed to fully arrest the progress of the disease.

4 Aug 2026

DNA Script and leading healthcare solutions provider awarded up to $26 M by ARPA-H to advance cell-free DNA bioproduction

DNA Script, a pioneer in DNA synthesis providing scientists with rapid, on-demand access to high-quality DNA, today announced that in collaboration with prime awardee GE HealthCare, they have been awarded up to $26 million in funding for a four-year initiative from the Advanced Research Projects Agency for Health (ARPA-H).

From DNA Script 4 Aug 2026